Fundraising FoxTerremotobio
South San Francisco, US · Founded 2022 · 6 known investors
Find your way into Terremotobio
Sign up to find every way you can get introduced to Terremotobio
- Your email: who you already know at Terremotobio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Terremotobio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Terremoto Biosciences is a clinical-stage biotech developing precision therapies for oncology and genetic diseases using lysine-targeted covalent chemistry. It pursues both best-in-class treatments against known drug targets and first-in-class medicines against previously undruggable targets.
Founders & leadership
Board
Investors · 6
How we know: funding news · Not right? Tell us
How we know: OrbiMed's portfolio page · a partner's Signal profile · press coverage · funding news · Not right? Tell us
How we know: RA Capital's portfolio page · press coverage · funding news · Not right? Tell us
How we know: press coverage · funding news · Not right? Tell us
How we know: press coverage · funding news · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · press coverage · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$40.7M disclosed across 1 of 2 rounds · 2023–2026
- Undisclosed amountseries BNov 2023Source ↗
▶$40.7MraisedApr 2026 · 14 investors · BiotechnologyRule 506(b)
- Michael GollerDirector
- Grace LuExecutive Officer
- James ChristensenExecutive Officer, Director
- Reid HuberDirector
- Peter ThompsonDirector
- Daniel O'ConnellDirector
- Charles BaumExecutive Officer, Director
- Offering amount
- $108.6M
- Amount sold
- $40.7M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Terremotobio went on to found or lead other companies.
In the news
Frequently asked questions
- What does Terremotobio do?
- Terremoto Biosciences is a clinical-stage biotech developing precision therapies for oncology and genetic diseases using lysine-targeted covalent chemistry. It pursues both best-in-class treatments against known drug targets and first-in-class medicines against previously undruggable targets.
- Who are Terremotobio's investors?
- Terremotobio's investors include EcoR1 Capital, OrbiMed, RA Capital, Novo Holdings, Osage University Partners, Third Rock Ventures.
- How much funding has Terremotobio raised?
- Terremotobio has disclosed $40.7M raised across 1 of its 2 known rounds.
- Where is Terremotobio headquartered?
- Terremotobio is headquartered in South San Francisco, US.